glycerylphosphorylcholine has been researched along with Dementia, Vascular in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chiti, G; Donnini, I; Fierini, F; Melone, A; Pantoni, L; Pescini, F; Poggesi, A; Rinnoci, V; Salvadori, E; Squitieri, M; Tudisco, L | 1 |
Amenta, F; Mignini, F; Parnetti, L; Tomassoni, D; Traini, E | 1 |
Barbagallo Sangiorgi, G; Barbagallo, M; Giordano, M; Meli, M; Panzarasa, R | 1 |
Amenta, F; Gallai, V; Parnetti, L | 1 |
1 review(s) available for glycerylphosphorylcholine and Dementia, Vascular
Article | Year |
---|---|
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Topics: Acetylcholine; Animals; Brain; Cognition Disorders; Cytidine Diphosphate Choline; Dementia, Vascular; Glycerylphosphorylcholine; Humans; Neuroprotective Agents; Nootropic Agents; Phospholipids | 2007 |
2 trial(s) available for glycerylphosphorylcholine and Dementia, Vascular
Article | Year |
---|---|
Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial-the CONIVaD trial.
Topics: Aged; Calcium Channel Blockers; Cerebral Small Vessel Diseases; Cognitive Dysfunction; Dementia, Vascular; Drug Therapy, Combination; Female; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Nimodipine; Randomized Controlled Trials as Topic | 2020 |
alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Dementia, Vascular; Female; Glycerylphosphorylcholine; Humans; Male; Middle Aged | 1994 |
1 other study(ies) available for glycerylphosphorylcholine and Dementia, Vascular
Article | Year |
---|---|
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Cognition Disorders; Dementia, Vascular; Glycerylphosphorylcholine; Humans; Parasympathomimetics; Periodicals as Topic; Statistics as Topic | 2001 |